Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Paxmedica, Inc. (PXMD) since 2023 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Paxmedica, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1811623.
Total stock buying since 2023: $0.
Total stock sales since 2023: $487,648.
Total stock option exercises since 2023: $0.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2024 | 0 | $0 | 1,288 | $612 | 0 | $0 |
2023 | 0 | $0 | 356,046 | $487,036 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2024-01 | 0 | $0 | 1,288 | $612 | 0 | $0 |
2023-11 | 0 | $0 | 12 | $12 | 0 | $0 |
2023-10 | 0 | $0 | 35,774 | $6,704 | 0 | $0 |
2023-08 | 0 | $0 | 50,797 | $28,264 | 0 | $0 |
2023-03 | 0 | $0 | 269,463 | $452,056 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-01-29 | Coelho John F | Sale | 27 | .48 | 12 |
2024-01-29 | Larochelle Karen | Sale | 78 | .48 | 37 |
2024-01-29 | Weisman Howard J. (Chief Executive Officer) | Sale | 372 | .47 | 174 |
2024-01-29 | Rome Zachary | Sale | 811 | .48 | 389 |
2023-11-27 | Coelho John F (Director) | Sale | 12 | 1.02 | 12 |
2023-10-27 | Coelho John F (Director) | Sale | 570 | .19 | 108 |
2023-10-27 | Larochelle Karen (Director) | Sale | 1,679 | .19 | 317 |
2023-10-27 | Weisman Howard J. (Chairman and CEO) | Sale | 8,049 | .19 | 1,521 |
2023-10-27 | Derby Michael (10% Owner) | Sale | 9,175 | .19 | 1,743 |
2023-10-27 | Rome Zachary (Director) | Sale | 16,301 | .18 | 3,015 |
2023-08-29 | Coelho John F (Director) | Sale | 23 | .49 | 11 |
2023-08-28 | Coelho John F (Director) | Sale | 774 | .52 | 403 |
2023-08-22 | Rome Zachary (Director) | Sale | 30,000 | .54 | 16,230 |
2023-08-21 | Rome Zachary (Director) | Sale | 20,000 | .58 | 11,620 |
2023-03-09 | Coelho John F | Sale | 130 | 1.48 | 192 |
2023-03-09 | Larochelle Karen | Sale | 335 | 1.48 | 495 |
2023-03-09 | Weisman Howard J. (Chief Executive Officer) | Sale | 3,495 | 1.44 | 5,032 |
2023-03-09 | Derby Michael (Executive Chairman) | Sale | 2,143 | 1.43 | 3,064 |
2023-03-09 | Rome Zachary (Chief Operating Officer) | Sale | 3,371 | 1.44 | 4,854 |
2023-03-08 | Weisman Howard J. (Chief Executive Officer) | Sale | 32,397 | 1.46 | 47,299 |
2023-03-08 | Rome Zachary (Chief Operating Officer) | Sale | 30,034 | 1.47 | 44,149 |
2023-03-07 | Weisman Howard J. (Chief Executive Officer) | Sale | 23,551 | 1.53 | 36,033 |
2023-03-07 | Derby Michael (Executive Chairman) | Sale | 15,134 | 1.55 | 23,457 |
2023-03-07 | Rome Zachary (Chief Operating Officer) | Sale | 23,432 | 1.53 | 35,850 |
2023-03-06 | Weisman Howard J. (Chief Executive Officer) | Sale | 13,589 | 1.72 | 23,373 |
2023-03-06 | Derby Michael (Executive Chairman) | Sale | 13,828 | 1.72 | 23,784 |
2023-03-06 | Rome Zachary (Chief Operating Officer) | Sale | 13,560 | 1.72 | 23,323 |
2023-03-03 | Larochelle Karen | Sale | 1,097 | 1.90 | 2,084 |
2023-03-03 | Weisman Howard J. (Chief Executive Officer) | Sale | 15,323 | 1.90 | 29,113 |
2023-03-03 | Derby Michael (Executive Chairman) | Sale | 18,968 | 1.90 | 36,039 |
2023-03-03 | Rome Zachary (Chief Operating Officer) | Sale | 13,199 | 1.89 | 24,946 |
2023-03-02 | Coelho John F | Sale | 3,013 | 1.93 | 5,815 |
2023-03-02 | Larochelle Karen | Sale | 7,736 | 1.94 | 15,007 |
2023-03-02 | Weisman Howard J. (Chief Executive Officer) | Sale | 11,679 | 1.94 | 22,657 |
2023-03-02 | Derby Michael (Executive Chairman) | Sale | 10,497 | 1.94 | 20,364 |
2023-03-02 | Rome Zachary (Chief Operating Officer) | Sale | 12,952 | 1.94 | 25,126 |
Insider trading activities including stock purchases, stock sales, and option exercises of PXMD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Paxmedica, Inc. (symbol PXMD, CIK number 1811623) see the Securities and Exchange Commission (SEC) website.